The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up
Open accessAbstract
In persistent hyperinsulinemic hypoglycemia of infancy (PHHI), the long term outcome of the disease is not well documented. Previous reports suggested that partial pancreatectomy in infants does not endanger future islet function. We evaluated endocrine pancreatic function in 14 PHHI patients 6.5-21 yr after diagnosis. Eight underwent early subtotal pancreatectomy, and 6 were medically treated; all were in clinical remission. Intravenous glucose tolerance and C-peptide suppression tests were performed, with multiple determinations of hormone levels. The insulin response to glucose was blunted in all pancreatectomized and in 2 conservatively treated patients. Glucose disposal was reduced in 6 pancreatectomized patients and in 2 medically treated subjects. Six of the pancreatectomized patients, including two with normal glucose disposal at first evaluation, developed overt diabetes during puberty. None in the medically treated group became diabetic; however, only 2 patients have reached puberty. C-Peptide suppression in response to hypoglycemia was inadequate in 4 of 5 pancreatectomized and 3 of 5 nonpancreatectomized patients studied. These results show that children with PHHI have impaired insulin responses to glucose and lack of suppressibility of endogenous insulin secretion several years after clinical remission. Thus, the beta-cell defect responsible for the disease in infancy is not corrected with time despite the disappearance of spontaneous hypoglycemia. Insulin secret…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While a low carbohydrate diet or α -glucosidase inhibitors are not effective in most patients, the potassium channel activator diazoxide has been shown to alleviate symptoms in some cases [58,59].”
In the citing paper
“While a low carbohydrate diet or α -glucosidase inhibitors are not effective in most patients, the potassium channel activator diazoxide has been shown to alleviate symptoms in some cases [58,59].”
Citations
Cites
Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.
Bonner‐Weir, S., Trent, D. F., & Weir, G. C. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110910 · Cited by 462
Amiel, S. A., Tamborlane, W. V., Simonson, D. C., & Sherwin, R. S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162205 · Cited by 309
Effects of Hemipancreatectomy on Insulin Secretion and Glucose Tolerance in Healthy Humans
Kendall, D. M., Sutherland, D. E. R., Najarian, J. S., Goetz, F. C., & Robertson, R. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003293221305 · Cited by 244
Reversibility of unawareness of hypoglycemia in patients with insulinomas.
Mitrakou, A., Fanelli, C., Veneman, T., Perriello, G., Calderone, S., Platanisiotis, D., Rambotti, A., Raptis, S., Brunetti, P., Cryer, P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309163291203 · Cited by 221
Aynsley-Green, A., Polak, J. M., Bloom, S. R., Gough, M., Keeling, J. W., Ashcroft, S. J. H., Turner, R. C., & Baum, J. D. (1981) · Archives of Disease in Childhood · doi:10.1136/adc.56.7.496 · Cited by 206
Gläser, B., Hirsch, H. J., & Landau, H. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80970-9 · Cited by 160
Self-citationShort- and long-term use of octreotide in the treatment of congenital hyperinsulinism
Thorton, P. S., & Alter, C. A. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80969-2 · Cited by 159
Hyperinsulinism in Infants and Children: Diagnosis and Therapy*
Stanley, C. A., & Baker, L. (1976) · Advances in Pediatrics · doi:10.1016/s0065-3101(22)00724-1 · Cited by 126
Nesidioblastosis and endocrine hyperplasia of the pancreas: A secondary phenomenon
Goudswaard, W. B., Houthoff, H. J., Koudstaal, J., & Zwierstra, R. P. (1986) · Human Pathology · doi:10.1016/s0046-8177(86)80154-x · Cited by 70
Persistent Neonatal Hypoglycemia Due to Hyperinsulinism: Medical Aspects
Landau, H., Perlman, M., Meyer, S., Isacsohn, M., Krausz, M., Mayan, H., Lijovetzky, G., & Schiller, M. (1982) · PEDIATRICS · doi:10.1542/peds.70.3.440 · Cited by 59
Self-citation
Cited by
Sorted by citations
Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels
Aguilar‐Bryan, L., & Bryan, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.2.0361 · Cited by 698
Pearson, E. R., Boj, S. F., Steele, A. M., Barrett, T. G., Stals, K. L., Hamilton-Shield, J. P., Ellard, S., Ferrer, J. P., & Hattersley, A. T. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040118 · Cited by 436
Practical management of hyperinsulinism in infancy
Aynsley-Green, A., Hussain, K., Hall, J., Saudubray, J., Nihoul‐Feketé, C., de Lonlay, P., Brunelle, F., Otonkoski, T., Thornton, P., & Lindley, K. J. (2000) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.82.2.f98 · Cited by 298
Hyperinsulinism in Infancy: From Basic Science to Clinical Disease
Dunne, M. J., Cosgrove, K. E., Shepherd, R. M., Aynsley-Green, A., & Lindley, K. J. (2004) · Physiological Reviews · doi:10.1152/physrev.00022.2003 · Cited by 297
Clinical features of 52 neonates with hyperinsulinism.
de Lonlay-Debeney, P., Poggi-Travert, F., Fournet, J., Sempoux, C., Vici, C., Brunelle, F., Touati, G., Rahier, J., Junien, C., Nihoul-Fékété, C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401505 · Cited by 306
Metadata
- Authors
- Leibowitz, G., Glaser, B., Higazi, A. A., Salameh, M., Cerasi, E., & Landau, H.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1995-02
- Volume
- 80
- Issue
- 2
- Pages
- 386-392
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1967142752
- Cited by
- 156
- References
- 32
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 7 · 2014: 5 · 2013: 2 · 2012: 6
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hadassah Medical Organization
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- nesidioblastosis, diabetes mellitus, beta-cell dysfunction, subtotal pancreatectomy, glucose tolerance, glucose disposal, insulin secretion, long-term follow-up, puberty, medical treatment
- MeSH terms
- Adolescent, C-Peptide, Child, Diabetes Mellitus, Diazoxide, Female, Follow-Up Studies, Glucose Tolerance Test, Humans, Islets of Langerhans, Male, Pancreatectomy, Pancreatic Diseases, Prospective Studies, Time Factors, Octreotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
